Syncom Formulations (India) Limited (SYNCOMF) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Syncom Formulations (India) Limited (SYNCOMF) has a cash flow conversion efficiency ratio of 0.007x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs17.58 Million ≈ $190.08K USD) by net assets (Rs2.70 Billion ≈ $29.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Syncom Formulations (India) Limited balance sheet independence to measure how much of total assets are equity-financed.
Syncom Formulations (India) Limited - Cash Flow Conversion Efficiency Trend (2006–2025)
This chart illustrates how Syncom Formulations (India) Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check SYNCOMF cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Syncom Formulations (India) Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Syncom Formulations (India) Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Mpact Limited
JSE:MPT
|
-0.008x |
|
Bank Capital Indonesia Tbk
JK:BACA
|
-0.276x |
|
Choppies Enterprises Ltd
JSE:CHP
|
0.910x |
|
Ya Horng Electronic Co Ltd
TW:6201
|
0.023x |
|
RF Acquisition Corp III Ordinary Shares
NASDAQ:RFAM
|
-0.001x |
|
PRECIA SA EO -50
F:P1E0
|
N/A |
|
Smec Co.Ltd
KQ:099440
|
-0.027x |
|
Ceres Global Ag Corp
TO:CRP
|
0.066x |
Annual Cash Flow Conversion Efficiency for Syncom Formulations (India) Limited (2006–2025)
The table below shows the annual cash flow conversion efficiency of Syncom Formulations (India) Limited from 2006 to 2025. For the full company profile with market capitalisation and key ratios, see SYNCOMF market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs3.42 Billion ≈ $37.00 Million |
Rs234.36 Million ≈ $2.53 Million |
0.068x | +430.29% |
| 2024-03-31 | Rs2.87 Billion ≈ $31.07 Million |
Rs-59.58 Million ≈ $-644.37K |
-0.021x | -150.42% |
| 2023-03-31 | Rs2.56 Billion ≈ $27.69 Million |
Rs105.29 Million ≈ $1.14 Million |
0.041x | -44.03% |
| 2022-03-31 | Rs2.22 Billion ≈ $24.03 Million |
Rs163.29 Million ≈ $1.77 Million |
0.073x | +791.44% |
| 2021-03-31 | Rs1.88 Billion ≈ $20.29 Million |
Rs-19.93 Million ≈ $-215.59K |
-0.011x | -206.10% |
| 2020-03-31 | Rs1.46 Billion ≈ $15.75 Million |
Rs-5.06 Million ≈ $-54.69K |
-0.003x | -110.64% |
| 2019-03-31 | Rs1.33 Billion ≈ $14.34 Million |
Rs43.29 Million ≈ $468.17K |
0.033x | +348.68% |
| 2018-03-31 | Rs1.22 Billion ≈ $13.19 Million |
Rs-16.01 Million ≈ $-173.10K |
-0.013x | -111.13% |
| 2017-03-31 | Rs1.17 Billion ≈ $12.69 Million |
Rs138.41 Million ≈ $1.50 Million |
0.118x | -46.97% |
| 2016-03-31 | Rs1.09 Billion ≈ $11.76 Million |
Rs241.74 Million ≈ $2.61 Million |
0.222x | +11832.06% |
| 2015-03-31 | Rs1.00 Billion ≈ $10.84 Million |
Rs1.87 Million ≈ $20.20K |
0.002x | -97.36% |
| 2014-03-31 | Rs951.99 Million ≈ $10.30 Million |
Rs67.30 Million ≈ $727.87K |
0.071x | +7.30% |
| 2013-03-31 | Rs877.09 Million ≈ $9.49 Million |
Rs57.79 Million ≈ $624.96K |
0.066x | -14.20% |
| 2012-03-31 | Rs836.08 Million ≈ $9.04 Million |
Rs64.20 Million ≈ $694.33K |
0.077x | +281.55% |
| 2011-03-31 | Rs816.58 Million ≈ $8.83 Million |
Rs-34.54 Million ≈ $-373.52K |
-0.042x | -381.24% |
| 2010-03-31 | Rs550.47 Million ≈ $5.95 Million |
Rs-4.84 Million ≈ $-52.32K |
-0.009x | +51.59% |
| 2009-03-31 | Rs411.32 Million ≈ $4.45 Million |
Rs-7.47 Million ≈ $-80.76K |
-0.018x | -112.90% |
| 2008-03-31 | Rs390.34 Million ≈ $4.22 Million |
Rs54.94 Million ≈ $594.11K |
0.141x | -0.43% |
| 2007-03-31 | Rs342.37 Million ≈ $3.70 Million |
Rs48.40 Million ≈ $523.37K |
0.141x | +69.71% |
| 2006-03-31 | Rs292.59 Million ≈ $3.16 Million |
Rs24.37 Million ≈ $263.55K |
0.083x | -- |
About Syncom Formulations (India) Limited
Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India and internationally. It operates through Manufacturing and Dealing in Pharmaceutical Drug and Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, dry syrups and su… Read more